-
Cancer chemotherapy and pharmacologyVrsta gradiva - časopisZaložništvo in izdelava - Berlin ; Heidelberg ; New York : SpringerJezik - angleškiISSN - 0344-5704COBISS.SI-ID - 25191424
Povezava(-e):
http://link.springer.com/journal/280El.arhiv:1995-
Polni tekst dostopen z računalnikov v mreži Medicinske fakultete
SHERPA/RoMEORevija v inf. servisu SHERPA/RoMEO - politike založnikov za objavljanje in arhiviranje v odprtem dostopu
SHERPA/RoMEO Journal - Publisher copyright policies & self-archiving (open access)
SpringerLink Springer - VerlagCelotno besedilo dostopno za uporabnike slovenskega konzorcija neprofitnih institucij SpringerLink od 1997
Full text accessible to the users of Slovenian Consortium of non-profit institutions SpringerLink from 1997 http://www.springerlink.com/
![loading ... loading ...](themes/default/img/ajax-loading.gif)
![loading ... loading ...](themes/default/img/ajax-loading.gif)
![loading ... loading ...](themes/default/img/ajax-loading.gif)
![loading ... loading ...](themes/default/img/ajax-loading.gif)
Vnos na polico
Trajna povezava
- URL:
Faktor vpliva Cancer chemotherapy and pharmacology
Dostop do baze podatkov JCR je dovoljen samo uporabnikom iz Slovenije. Vaš trenutni IP-naslov ni na seznamu dovoljenih za dostop, zato je potrebna avtentikacija z ustreznim računom AAI.
Leto | Faktor vpliva | Izdaja | Kategorija | Razvrstitev | ||||
---|---|---|---|---|---|---|---|---|
JCR | SNIP | JCR | SNIP | JCR | SNIP | JCR | SNIP | |
2020 | 0.893 |
SE
SE
SE
SE
SE
|
Cancer Research
Oncology
Pharmacology
Toxicology
Pharmacology (medical)
|
113/211
172/351
142/304
58/120
112/253
|
||||
2021 | 0.949 |
SE
SE
SE
SE
SE
|
Pharmacology (medical)
Toxicology
Cancer Research
Pharmacology
Oncology
|
96/254
46/123
107/211
123/309
164/361
|
||||
2018 | 0.956 |
SE
SE
SE
SE
SE
|
Pharmacology
Oncology
Pharmacology (medical)
Toxicology
Cancer Research
|
104/307
132/350
80/251
45/119
86/211
|
||||
2022 | 0.809 |
SE
SE
SE
SE
SE
|
Pharmacology
Oncology
Pharmacology (medical)
Cancer Research
Toxicology
|
145/303
177/360
117/258
115/209
62/122
|
||||
2019 | 1.028 |
SE
SE
SE
SE
SE
|
Pharmacology
Oncology
Pharmacology (medical)
Toxicology
Cancer Research
|
94/310
115/350
76/255
36/120
75/209
|
||||
2011 | 1.050 |
SE
SE
SE
SE
SE
|
Pharmacology
Oncology
Pharmacology (medical)
Toxicology
Cancer Research
|
88/323
74/283
55/229
36/112
59/176
|
||||
2015 | 0.985 |
SE
SE
SE
SE
SE
|
Toxicology
Pharmacology (medical)
Cancer Research
Oncology
Pharmacology
|
41/113
68/239
79/202
119/330
94/305
|
||||
2017 | 0.910 |
SE
SE
SE
SE
SE
|
Pharmacology
Oncology
Pharmacology (medical)
Cancer Research
Toxicology
|
104/304
145/345
79/250
92/209
48/115
|
||||
2012 | 0.988 |
SE
SE
SE
SE
SE
|
Pharmacology
Oncology
Pharmacology (medical)
Toxicology
Cancer Research
|
109/316
103/298
66/231
47/116
70/185
|
||||
2014 | 0.959 |
SE
SE
SE
SE
SE
|
Pharmacology (medical)
Cancer Research
Toxicology
Pharmacology
Oncology
|
75/236
80/193
49/116
106/311
118/315
|
||||
2010 | 0.960 |
SE
SE
SE
SE
SE
|
Pharmacology
Oncology
Pharmacology (medical)
Toxicology
Cancer Research
|
84/308
70/261
51/217
39/109
59/170
|
||||
2008 | 0.851 |
SE
SE
SE
SE
SE
|
Pharmacology (medical)
Toxicology
Cancer Research
Pharmacology
Oncology
|
60/200
45/95
62/150
104/272
77/227
|
||||
2016 | 0.931 |
SE
SE
SE
SE
SE
|
Oncology
Pharmacology
Pharmacology (medical)
Toxicology
Cancer Research
|
125/342
106/302
79/243
50/116
85/209
|
||||
2009 | 0.912 |
SE
SE
SE
SE
SE
|
Oncology
Pharmacology
Toxicology
Pharmacology (medical)
Cancer Research
|
69/240
98/285
46/102
59/208
57/158
|
||||
2013 | 0.982 |
SE
SE
SE
SE
SE
|
Oncology
Pharmacology
Pharmacology (medical)
Toxicology
Cancer Research
|
104/316
104/319
75/239
48/116
75/191
|
||||
2007 | 0.846 |
SE
SE
SE
SE
SE
|
Pharmacology
Oncology
Pharmacology (medical)
Toxicology
Cancer Research
|
106/264
81/216
65/184
39/91
68/145
|
||||
2006 | 0.787 |
SE
SE
SE
SE
SE
|
Pharmacology
Oncology
Toxicology
Pharmacology (medical)
Cancer Research
|
106/260
83/197
43/90
60/170
69/132
|
||||
2005 | 0.791 |
SE
SE
SE
SE
SE
|
Pharmacology
Oncology
Pharmacology (medical)
Toxicology
Cancer Research
|
112/259
75/196
59/171
41/89
61/130
|
||||
2004 | 0.897 |
SE
SE
SE
SE
SE
|
Oncology
Pharmacology
Pharmacology (medical)
Toxicology
Cancer Research
|
60/191
79/248
44/162
37/90
54/134
|
||||
2001 | 0.768 |
SE
SE
SE
SE
SE
|
Pharmacology (medical)
Toxicology
Cancer Research
Oncology
Pharmacology
|
37/142
35/89
40/111
46/145
69/214
|
||||
2000 | 0.772 |
SE
SE
SE
SE
SE
|
Oncology
Pharmacology
Pharmacology (medical)
Toxicology
Cancer Research
|
44/124
67/197
36/121
36/81
35/101
|
||||
2003 | 0.808 |
SE
SE
SE
SE
SE
|
Pharmacology
Oncology
Toxicology
Pharmacology (medical)
Cancer Research
|
80/247
63/176
36/94
46/157
52/129
|
||||
2002 | 0.737 |
SE
SE
SE
SE
SE
|
Pharmacology (medical)
Cancer Research
Toxicology
Oncology
Pharmacology
|
39/153
42/123
42/92
52/160
79/239
|
||||
1998 | ||||||||
1999 | 0.832 |
SE
SE
SE
SE
SE
|
Pharmacology (medical)
Toxicology
Cancer Research
Pharmacology
Oncology
|
31/115
34/85
30/96
61/196
37/123
|
||||
1995 | ||||||||
1994 | ||||||||
1996 | ||||||||
1997 |
Baze podatkov, v katerih je revija indeksirana
Ime baze podatkov | Področje | Leto |
---|---|---|
CINAHL | za medicino in zdravstveno nego | 2014 - 2016, 2018 - 2023 |
Medline | za medicino in stomatologijo | do 2023 |
Derwent Biotechnology Resource | za biotehnologijo | do 2013 |
Biological Abstracts | za biologijo | 2016 - 2023 |
CAB Abstracts | za biotehniko | do 2013 |
CAPlus (Chemical Abstracts Plus) | za kemijo | do 2013 |
BIOSIS Previews | za biologijo | do 2013, 2015 - 2016, 2018 - 2023 |
Scopus | za naravoslovne vede | do 2023 |
Science Citation Index Expanded (SCI-EXPANDED) | za naravoslovne vede | do 2023 |
PubMed | za medicino in stomatologijo | do 2023 |
Povezave do osebnih bibliografij avtorjev | Povezave do podatkov o raziskovalcih v sistemu SICRIS |
---|
Izberite prevzemno mesto:
Prevzem gradiva po pošti
Obvestilo
Gesla v Splošnem geslovniku COBISS
Izbira mesta prevzema
Mesto prevzema | Status gradiva | Rezervacija |
---|
Prosimo, počakajte trenutek.